CLINICAL IMPORTANCE OF B2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
dc.contributor.author | Kocak, M. Z. | |
dc.contributor.author | Dagli, M. | |
dc.contributor.author | Kutlucan, A. | |
dc.contributor.author | Basturk, A. | |
dc.contributor.author | Unlu, A. | |
dc.contributor.author | Acar, H. | |
dc.contributor.author | Kutlucan, L. | |
dc.date.accessioned | 2020-03-26T19:23:20Z | |
dc.date.available | 2020-03-26T19:23:20Z | |
dc.date.issued | 2016 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 21st Congress of the European-Hematology-Association -- JUN 09-12, 2016 -- Copenhagen, DENMARK | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | European Hematol Assoc | en_US |
dc.identifier.endpage | 811 | en_US |
dc.identifier.issn | 0390-6078 | en_US |
dc.identifier.startpage | 811 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/33359 | |
dc.identifier.volume | 101 | en_US |
dc.identifier.wos | WOS:000379484603166 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | FERRATA STORTI FOUNDATION | en_US |
dc.relation.ispartof | HAEMATOLOGICA | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | CLINICAL IMPORTANCE OF B2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS | en_US |
dc.type | Conference Object | en_US |